Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (48.3), the stock would be worth ﷼-27.98 (148% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -100.5 | ﷼58.2 |
0%
|
| Industry Average | 48.3 | ﷼-27.98 |
-148%
|
| Country Average | 25.2 | ﷼-14.61 |
-125%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| SA |
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
9B SAR | -100.5 | 30.9 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.8B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.9B USD | 6.1 | 9.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.7B USD | 29.2 | 30.7 |
Market Distribution
| Min | 1.2 |
| 30th Percentile | 16.8 |
| Median | 25.2 |
| 70th Percentile | 44.6 |
| Max | 11 988.3 |
Other Multiples
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View
In the bustling hub of healthcare innovation within the Kingdom of Saudi Arabia, Dr. Soliman Abdel Kader Fakeeh Hospital Company SCJSC stands out as a beacon of medical excellence and pioneering spirit. Founded to address the rising demand for quality healthcare services in the region, the company has grown from a single hospital into a comprehensive network of medical facilities. The core of its operations revolves around providing a full spectrum of healthcare services ranging from basic outpatient treatments to intricate surgical procedures and specialty care. The company integrates advanced medical technologies with a patient-focused care approach, ensuring that the population it serves receives both cutting-edge and compassionate treatment. Within its walls, dedicated teams of healthcare professionals work tirelessly to uphold a legacy of trust and expertise, attracting both local and international patients seeking superior medical attention. Financially, Dr. Soliman Abdel Kader Fakeeh Hospital Company operates through a multifaceted model that revolves around patient services, strategic partnerships, and insurance collaborations. By catering to a diverse array of medical needs, the company secures a steady revenue stream from its inpatient and outpatient services. Moreover, it has established alliances with various insurance companies, streamlining the payment processes for insured patients and enhancing financial access to healthcare services. Strategic expansions and the introduction of specialized units also contribute significantly to its revenue, allowing it to capture more market share and cater to niche medical needs. The organization's business acumen is evident in its ability to balance quality care with economic sustainability, ensuring its growth while maintaining high standards of healthcare delivery across the kingdom.